Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Condition(s):Vestibular Schwannoma; Neurofibromatosis Type 2Last Updated:September 9, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Vestibular Schwannoma; Neurofibromatosis Type 2Last Updated:September 9, 2021Completed
Condition(s):Lung Cancer Stage IVLast Updated:May 16, 2017Unknown status
Condition(s):NSCLCLast Updated:May 8, 2017Unknown status
Condition(s):Non-Small Cell Lung CancerLast Updated:August 24, 2022Not yet recruiting
Condition(s):Lung CancerLast Updated:March 24, 2015Unknown status
Condition(s):EGF-R Positive Non-Small Cell Lung CancerLast Updated:November 21, 2018Recruiting
Condition(s):Non-Small Cell Lung Cancer; Brain MetastasesLast Updated:November 27, 2018Unknown status
Condition(s):EGFR Gene Mutation; Non Small Cell Lung Cancer Stage IIIA; Non Small Cell Lung Cancer Stage IIIBLast Updated:July 18, 2018Unknown status
Condition(s):EGF-R Positive Non-Small Cell Lung CancerLast Updated:July 18, 2018Unknown status
Condition(s):Non-small Cell Lung CancerLast Updated:November 11, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.